GITEX Global 2025 showcases nation-scale AI, quantum computing, and cross-sector MoUs to drive the digital economy.
DUBAI: Day 2 of GITEX Global 2025 witnessed record-breaking attendance and high-impact discussions as industry leaders spotlighted nation-scale AI, quantum computing, and strategic partnerships to power the next phase of the digital economy. Taking place at Dubai World Trade Centre until 17 October, the 45th edition features over 6,800 exhibitors from 180+ countries.
A headline virtual dialogue between Sam Altman of OpenAI and Peng Xiao of G42 kicked off the day, followed by sessions from Microsoft, Oracle, IBM, and others exploring the future of AI-native societies. The focus was firmly on building autonomous infrastructure, powered by sovereign AI and open-source systems. Jim Keller, CEO of Tenstorrent, urged nations to “own their AI future” through open innovation.
IBM’s Ana Paula Assis shared how quantum computing can unlock real-time parallel operations, paving the way for groundbreaking AI use-cases. Meanwhile, investor Paul Palandjian from O’Leary Ventures emphasised the looming global power crisis amid rising demand for hyperscale data centres and AI computing.
In the creative space, SoundCloud’s CEO Eliah Seton raised concerns about AI-generated music infringing on human creativity and IP, calling for ethical transparency and content tagging in the age of generative models.
On the exhibition floor, AI71 showcased applied AI for governments and businesses, HPE revealed scalable sovereign AI solutions, and JetBrains introduced its AI coding assistants. Local robotics firm Mangobot wowed crowds with its humanoid and “Wolf Pack” robotic dogs, while Micropolis debuted an AI-powered autonomous police vehicle.
Key MoUs signed included Microsoft-Dubai Municipality for cloud and cybersecurity, Deloitte-IBM for enterprise AI acceleration, and First Abu Dhabi Bank with UAE Media Council, reflecting strong multi-sector cooperation.
GITEX Global 2025 continues to break new ground, with Day 3 set to spotlight biotech, gene-editing, and AI-driven healthcare revolutions.
